Skip to main content

Table 2 Exclusion criteria of the study protocol

From: The effectiveness of antioxidant vitamins C and E in reducing myocardial infarct size in patients subjected to percutaneous coronary angioplasty (PREVEC Trial): study protocol for a pilot randomized double-blind controlled trial

Exclusion criteria

1

History of renal or hepatic insufficiency

2

History of renal lithiasis

3

History of heart failure (New York Heart Association III, IV)

4

Cardiogenic shock

5

Postprimary PCA TIMI grade flow of 0, 1, or 2

6

Any serious medical comorbidity that determines life expectancy <6 months

7

Current participation in any other clinical investigation

8

Pregnancy

9

Glucose 6-phosphate dehydrogenase deficiency